Inhaled Bronchodilator Association and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease

Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00624286 ·Status: COMPLETED ·Phase: PHASE3

Symbicort in Chronic Obstruktive Pulmonary Disease

NCT00612976 ·Status: COMPLETED

Dose Ranging Study of Ba 679 BR Inhalation Powder in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT02172352 ·Status: COMPLETED ·Phase: PHASE2

A Study To Examine The Safety, Pharmacokinetics And Pharmacodynamics Of PF-03635659 In Patients With Chronic Obstructive Pulmonary Disease

NCT01033487 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)

NCT00665600 ·Status: COMPLETED ·Phase: PHASE3

Simvastatin in Chronic Obstructive Pulmonary Disease (COPD)

NCT00680641 ·Status: UNKNOWN ·Phase: PHASE4

Individualized Dosing Schedule of Inhaled Bronchodilator for Endotracheally Intubated COPD Patients

NCT01933984 ·Status: COMPLETED ·Phase: NA

A Study to Assess the Long-term Safety of QVA149

NCT01120717 ·Status: COMPLETED ·Phase: PHASE3

Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease

NCT00984659 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks

NCT01068600 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy

NCT00791518 ·Status: COMPLETED

Efficacy and Safety of the Addition of Fluticanse Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide (62.5 or 125mcg) Once-daily Over 12 Weeks

NCT01772134 ·Status: COMPLETED ·Phase: PHASE3

NVA237 Versus Placebo 12-week Efficacy Study

NCT01709864 ·Status: COMPLETED ·Phase: PHASE3

A Safety, Pharmacokinetic and Pharmacodynamic Study of PUR0200 in COPD Patients

NCT01921712 ·Status: COMPLETED ·Phase: PHASE1

Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease

NCT02177253 ·Status: COMPLETED ·Phase: PHASE3

IMD-1041 Chronic Obstructive Pulmonary Disease: Proof of Concept (POC) Study

NCT00883584 ·Status: UNKNOWN ·Phase: PHASE2

Evaluating Bronchodilator Response in Patients With Bronchiectasis

NCT05932316 ·Status: UNKNOWN ·Phase: NA

A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.

NCT01727141 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Two Fixed-dose Combinations of Aclidinium Bromide With Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and Placebo

NCT01049360 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess the Effect of Formoterol and Beclomethasone Dipropionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT01204034 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Aclidinium Bromide at Two Dose Levels Versus Placebo Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT01001494 ·Status: COMPLETED ·Phase: PHASE3

Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease

NCT01019694 ·Status: COMPLETED ·Phase: PHASE3

Assessing Optimal Inhaler Strategies During Acute Exacerbations of COPD (AECOPDs) Using Oscillometry

NCT06495047 ·Status: COMPLETED

12-week Efficacy of Indacaterol

NCT01072448 ·Status: COMPLETED ·Phase: PHASE3

Efficacy Study of the Effect of Budesonide on Emphysema

NCT00232674 ·Status: COMPLETED ·Phase: PHASE4